Scinogy
Scinogy delivers automated, single‑use manufacturing platforms to make cell‑therapy production faster, cheaper, and commercially viable.
Private Company
Funding information not available
AI Company Overview
Scinogy delivers automated, single‑use manufacturing platforms to make cell‑therapy production faster, cheaper, and commercially viable.
Technology Platform
Scinogy’s core technology is a modular, single‑use, closed‑system platform (Rotea) that integrates counter‑flow centrifuges, automated bag‑mixing, and real‑time process control to enable efficient, GMP‑compliant cell‑therapy manufacturing.
Opportunities
Risk Factors
Competitive Landscape
Scinogy competes with large CDMOs such as Lonza and Thermo Fisher, differentiating itself through a focus on single‑use, highly automated systems that promise lower cost and faster turnaround.